Literature DB >> 7776888

Quantitative combined phosphorus and proton PRESS of the brains of newborn human infants.

E B Cady1.   

Abstract

Techniques for quantitative, combined phosphorus and proton, point-resolved spectroscopy (PRESS) studies of newborn-infant brain have been developed. Phosphorus PRESS advantages include: voxel-shimming; rapid transmitter-pulse setting; novel use of brain-water as a localized quantitation reference; and reduced broad components. Proton spectra from 1-ml voxels and phosphorus spectra can both be acquired quantitatively within acceptable time. Cerebral lactate was consistently detected by proton PRESS and the normal concentration (approximately 3 mmol/kg wet weight) may be higher than in adult brain. Phosphorus PRESS provided metabolite peak-area ratios and concentrations comparable with those obtained using ISIS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776888     DOI: 10.1002/mrm.1910330415

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  4 in total

1.  Cerebral energy metabolism in isovaleric acidaemia.

Authors:  A K Lorek; J M Penrice; E B Cady; J V Leonard; J S Wyatt; R A Iles; S P Burns; E O Reynolds
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

2.  Metabolite concentrations and relaxation in perinatal cerebral hypoxic-ischemic injury.

Authors:  E B Cady
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

3.  Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.

Authors:  C S Zuo; P V Prasad; P Busse; L Tang; R G Zamenhof
Journal:  Med Phys       Date:  1999-07       Impact factor: 4.071

4.  Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations.

Authors:  J L Y Cheong; E B Cady; J Penrice; J S Wyatt; I J Cox; N J Robertson
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.